Atul is currently trading at Rs. 1453.85, up by 93.60 points or 6.88 % from its previous closing of Rs. 1360.25 on the BSE.
The scrip opened at Rs. 1365.80 and has touched a high and low of Rs. 1514.00 and Rs. 1360.95 respectively. So far 29423 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1495.00 on 22-Sep-2014 and a 52 week low of Rs. 395.10 on 04-Feb-2014.
Last one week high and low of the scrip stood at Rs. 1398.00 and Rs. 1280.10 respectively. The current market cap of the company is Rs. 4324.68 crore.
The promoters holding in the company stood at 50.68 % while Institutions and Non-Institutions held 17.88 % and 31.45 % respectively.
Atul’s Dapsone manufacture facility located at Valsad in state of Gujarat has been approved by the US Food and Drug Administration (USFDA).
The company has two business segments, namely, ‘Life Science Chemicals’ and ‘Performance and Other Chemicals’. The Life Science Chemical segment comprises several manufacturing facilities which also include Dapsone manufacture facility.
Atul is a member of Lalbhai Group, one of the oldest business houses of India, with interests mainly in textiles and chemicals. The Group is strongly committed to serve the society in the fields of education, health as well as culture
| Company Name | CMP |
|---|---|
| BASF India | 4035.90 |
| Tata Chemicals | 782.10 |
| SRF | 2780.75 |
| Pidilite Inds. | 1476.15 |
| Deepak Nitrite | 1875.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: